<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
61480-105-03
</NDCCode>
<PackageDescription>
237 mL in 1 BOTTLE (61480-105-03)
</PackageDescription>
<NDC11Code>
61480-0105-03
</NDC11Code>
<ProductNDC>
61480-105
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Psoriasis
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Niccolum Sulphuricum, Natrum Bromatum, Zincum Bromatum, Kali Bromatum, Kali Sulphuricum.
</NonProprietaryName>
<DosageFormName>
LIQUID
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20161212
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
UNAPPROVED HOMEOPATHIC
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
PLYMOUTH HEALTHCARE PRODUCTS LLC
</LabelerName>
<SubstanceName>
NICKEL SULFATE HEXAHYDRATE; POTASSIUM BROMIDE; POTASSIUM SULFATE; SODIUM BROMIDE; ZINC BROMIDE
</SubstanceName>
<StrengthNumber>
3; 1; 4; 2; 4
</StrengthNumber>
<StrengthUnit>
[hp_X]/237mL; [hp_X]/237mL; [hp_X]/237mL; [hp_X]/237mL; [hp_X]/237mL
</StrengthUnit>
<Pharm_Classes>
Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2025-11-21
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20161212
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>